Neural Analysis System Combining aEEG and rEEG for Preterm Brain Monitoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic and therapeutic systems for preterm infants and neural disorders lack enhanced analysis and treatment capabilities, particularly in monitoring brain maturation and neurological status, as they rely on conventional EEG methods that do not fully account for stimulation's impact on brain development.
Innovation Solution
A neural analysis and treatment system combining amplitude-integrated electroencephalography (aEEG) and range-electroencephalography (rEEG) information to determine neural characteristics, quantify spectral edge frequency modulation, and promote cortical adaptation through therapeutic stimuli like pulsed orocutaneous stimulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional EEG methods are used to monitor preterm infants, then the system is simple and easy to operate, but the measurement precision and diagnostic capability are insufficient
Solution Approach 1:
The patent combines amplitude-integrated electroencephalography (aEEG) and range-electroencephalography (rEEG) into a unified system that processes both signal types through a single computing device. The system merges conventional EEG monitoring with advanced spectral analysis capabilities, allowing simultaneous acquisition of multiple EEG parameters without requiring separate diagnostic systems. This integration resolves the contradiction by improving measurement precision through comprehensive data analysis while maintaining operational simplicity through unified system architecture.
Solution Approach 2:
The computing device is designed to perform multiple functions: it processes aEEG signals for basic brain activity monitoring, analyzes rEEG signals for spectral characteristics, determines spectral edge frequency (SEF) values, and provides diagnostic assessments. This multi-functional approach eliminates the need for separate specialized systems, thereby improving diagnostic capability without proportionally increasing system complexity.
2Measurement precision
If enhanced analysis capabilities including aEEG and rEEG are implemented, then diagnostic precision improves, but device complexity increases
Solution Approach 1:
The patent segments the EEG signal processing into distinct functional modules: aEEG processing for amplitude analysis, rEEG processing for range-based spectral analysis, SEF calculation for frequency domain characterization, and diagnostic assessment. This segmentation allows complex signal processing to be divided into manageable stages, each handled by dedicated processing logic within the unified computing device. The modular approach manages processing complexity while maintaining high diagnostic precision through specialized analysis at each stage.
3Reliability
If therapeutic interventions based on neural analysis are provided, then treatment effectiveness improves, but system complexity increases
Solution Approach 1:
The system implements feedback mechanisms where neural analysis results directly inform therapeutic intervention decisions. The computing device processes EEG data, determines neural characteristics such as spectral edge frequency and asymmetry indices, and provides recommendations for targeted therapies. This closed-loop feedback approach ensures that treatment effectiveness is continuously monitored and adjusted based on real-time neural data, improving reliability while managing complexity through automated decision-support algorithms.
Data Source
AI summary
A neural analysis and treatment system includes a computing device with a memory for storing an application that is executable on a processor to receive amplitude-integrated electroencephalography (aEEG) and range-EEG (rEEG) measurements associated with a patient. The systems determine a spectral edge frequency (SEF) measurement from the received EEG measurements, and determine one or more neural characteristics of the patient according to the determined SEF, aEEG, and rEEG measurements. These neural characteristics may then be used to identify and implement an appropriate therapeutic treatment.